Bone Biologics (BBLG) Assets (2012 - 2025)
Bone Biologics (BBLG) reported Assets of $5.8 million for Q4 2025, up 50.11% year-over-year from $3.9 million in Q4 2024, and down 8.73% quarter-over-quarter from $6.4 million in Q3 2025.
Bone Biologics (BBLG) Assets (2012 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 14 years of Assets data on file, last reported at $5.8 million in Q4 2025.
- Assets for Q4 2025 came in at $5.8 million, up 50.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.8 million (up 50.11% YoY), and the FY2025 annual result was $5.8 million, up 50.11% from the prior year.
- Assets fell to $5.8 million in Q4 2025 per BBLG's latest filing, from $6.4 million in the prior quarter.
- Over five years, Assets peaked at $8.5 million in Q4 2022 and troughed at $4438.0 in Q2 2021.
- A 5-year average of $4.6 million and a median of $5.1 million in 2022 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2024: Assets jumped 127409.71% in 2022, then plunged 58.11% in 2024.
- A 5-year view of Assets shows it stood at $6.7 million in 2021, then gained by 27.26% to $8.5 million in 2022, then slumped by 56.0% to $3.7 million in 2023, then rose by 3.31% to $3.9 million in 2024, then soared by 50.11% to $5.8 million in 2025.
- Business Quant data shows BBLG's Assets at $5.8 million in Q4 2025, $6.4 million in Q3 2025, and $7.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 33.89 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 23.64 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 640.56 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | 5.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 6.35 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 3.16 Mn |
| Dec 31, 2024 | 3.86 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Dec 31, 2023 | 3.74 Mn |
| Sep 30, 2023 | 4.98 Mn |
| Jun 30, 2023 | 7.62 Mn |
| Mar 31, 2023 | 6.78 Mn |
| Dec 31, 2022 | 8.50 Mn |
| Sep 30, 2022 | 5.20 Mn |
| Jun 30, 2022 | 5.66 Mn |
| Mar 31, 2022 | 6.09 Mn |
| Dec 31, 2021 | 6.68 Mn |
| Sep 30, 2021 | 52,393.00 |
| Jun 30, 2021 | 4,438.00 |
| Mar 31, 2021 | 71,165.00 |